Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Etamicastat in Healthy Young and Elderly Males
NCT03090724Phase 1Completed
- Sponsor
- BIAL
- Start
- Jun 2008
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of etamicastat in hypertension (HTN) and chronic heart failure (CHF) (2 arms), sponsored by BIAL. Primary endpoints: Maximum observed plasma concentration at Day 12, Time to maximum observed plasma concentration at Day 12 and 3 more. Started Jun 2008; status: completed.
02
Drugs
etamicastat
03
Conditions
hypertension (HTN)chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT03090724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090724.